These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9309372)

  • 1. Safety evaluation of chronic fluconazole therapy. Fluconazole Pan-American Study Group.
    Stevens DA; Diaz M; Negroni R; Montero-Gei F; Castro LG; Sampaio SA; Borelli D; Restrepo A; Franco L; Bran JL; Arathoon EG
    Chemotherapy; 1997; 43(5):371-7. PubMed ID: 9309372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia associated with fluconazole therapy.
    Pappas PG; Kauffman CA; Perfect J; Johnson PC; McKinsey DS; Bamberger DM; Hamill R; Sharkey PK; Chapman SW; Sobel JD
    Ann Intern Med; 1995 Sep; 123(5):354-7. PubMed ID: 7625624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole treatment of neonates and infants with severe fungal infections.
    Gürpinar AN; Balkan E; Kiliç N; Kiriştioğlu I; Avşar I; Doğruyol H
    J Int Med Res; 1997; 25(4):214-8. PubMed ID: 9283996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group.
    Diaz M; Negroni R; Montero-Gei F; Castro LG; Sampaio SA; Borelli D; Restrepo A; Franco L; Bran JL; Arathoon EG
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S68-76. PubMed ID: 1562698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Level of evidence for therapeutic drug monitoring of fluconazole].
    Venisse N; Le Guellec C
    Therapie; 2011; 66(2):97-101. PubMed ID: 21635855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluconazole treatment of systemic mycoses].
    Mori T; Matsumura M; Ebe T; Takahashi M; Kohara T; Inagaki M; Isonuma H; Hibiya I; Hamamoto T; Watanabe K
    Jpn J Antibiot; 1989 Jan; 42(1):55-62. PubMed ID: 2540368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Pappas PG; Bradsher RW; Kauffman CA; Cloud GA; Thomas CJ; Campbell GD; Chapman SW; Newman C; Dismukes WE
    Clin Infect Dis; 1997 Aug; 25(2):200-5. PubMed ID: 9332510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose therapy with fluconazole > or = 800 mg day-1.
    Duswald KH; Penk A; Pittrow L
    Mycoses; 1997 Nov; 40(7-8):267-77. PubMed ID: 9476509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients.
    Wadhwa NK; Suh H; Cabralda T
    Adv Perit Dial; 1996; 12():189-91. PubMed ID: 8865899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
    Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S
    BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of fluconazole against fungal infections in hematological diseases].
    Morioka E; Asahara F; Nagano M; Kawasaki C; Yoshida T; Uchida T; Nakashima H; Suzumiya J; Kimura N; Hisano S; Okumura M
    Jpn J Antibiot; 1996 Apr; 49(4):399-402. PubMed ID: 8786630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical evaluation of fluconazole in deep seated fungal infections associated with hematological disorders].
    Murakami S; Misago M; Tohnai S; Nakanishi M; Ogawa R; Wake A; Nagata K; Mori N; Tsukada J; Nakata K; Oda S; Morimoto I; Eto S; Izumi Y; Sawada H; Yamasaki Y; Yamano Y; Ohmori F; Ohkuma K; Ohnishi Y; Yamamura M; Asano Y; Tanaka H; Ikeda K; Oda E
    Jpn J Antibiot; 1996 Jan; 49(1):95-105. PubMed ID: 8851308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy.
    Kami M; Sawada Y; Mori S; Hirate J; Kojima N; Kanda Y; Moriya A; Yuji K; Saito T; Chiba S; Hirai H
    Am J Hematol; 2001 Feb; 66(2):85-91. PubMed ID: 11421304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antifungal therapy in hospitalized patients. II. Results after the marketing of fluconazole.
    Grasela TH; Pasko MT; Goodwin SD; Walawander CA; Blackwelder N; Bruder-Holt RJ
    Ann Pharmacother; 1994 Feb; 28(2):261-70. PubMed ID: 8173148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
    Ito Y; Ohyashiki K; Yoshida I; Takeuchi M; Aoyama Y; Mugitani A; Matsuura Y; Wakita H; Matsuda M; Sakamoto E; Kiguchi T; Urabe A; Tamura K; Kanamaru A; Masaoka T
    Int J Hematol; 2007 Feb; 85(2):121-7. PubMed ID: 17321989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole-induced agranulocytosis with eosinophilia.
    Wong-Beringer A; Shriner K
    Pharmacotherapy; 2000 Apr; 20(4):484-6. PubMed ID: 10772380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystoid macular edema secondary to fluconazole toxicity.
    Magrath GN; Pulido JS; Montero J; Mason C; Wilson J
    Ocul Immunol Inflamm; 2010 Dec; 18(6):472-4. PubMed ID: 20735297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of fluconazole in children.
    Novelli V; Holzel H
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1955-60. PubMed ID: 10428919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.